MAPT and Alzheimer disease: Moreover, studies indicate that the activation of the RhoA/ROCK signaling pathway seems to induce Aβ aggregation [80], phosphorylated tau formation [82], neuroinflammation [83], synaptic damage [84], and other mechanisms, ultimately leading to AD [85].